Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 42, 2012 - Issue 6
419
Views
11
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

Effect of a traditional Chinese medicine Liu Wei Di Huang Wan on the activities of CYP2C19, CYP2D6 and CYP3A4 in healthy volunteers

, , , , , & show all
Pages 596-602 | Received 12 Oct 2011, Accepted 23 Nov 2011, Published online: 30 Dec 2011

References

  • Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK. (2007). In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Biomed Chromatogr 21:190–200.
  • Butler MA, Lang NP, Young JF, Caporaso NE, Vineis P, Hayes RB, Teitel CH, Massengill JP, Lawsen MF, Kadlubar FF. (1992). Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics 2:116–127.
  • Chen Y, Kang Z, Yan J, Yang GP, Tan ZR, Zhou G, Ouyang DS. (2010). Liu wei di huang wan, a well-known traditional Chinese medicine, induces CYP1A2 while suppressing CYP2A6 and N-acetyltransferase 2 activities in man. J Ethnopharmacol 132:213–218.
  • Cheng JT, Liu IM, Chi TC, Su HC, Chang CG. (2001). Stimulation of insulin release in rats by Die-Huang-Wan, a herbal mixture used in Chinese traditional medicine. J Pharm Pharmacol 53:273–276.
  • Goldstein JA, de Morais SM. (1994). Biochemistry and molecular biology of the human CYP2C subfamily. Pharmacogenetics 4:285–299.
  • Hsieh MT, Cheng SJ, Lin LW, Wang WH, Wu CR. (2003). The ameliorating effects of acute and chronic administration of LiuWei Dihuang Wang on learning performance in rodents. Biol Pharm Bull 26:156–161.
  • Hsu JH, Wu YC, Liu IM, Cheng JT. (2007). Dioscorea as the principal herb of Die-Huang-Wan, a widely used herbal mixture in China, for improvement of insulin resistance in fructose-rich chow-fed rats. J Ethnopharmacol 112:577–584.
  • Kim KA, Lee JS, Park HJ, Kim JW, Kim CJ, Shim IS, Kim NJ, Han SM, Lim S. (2004). Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes. Life Sci 74:2769–2779.
  • Li M, Wang W, Wang P, Yang K, Sun H, Wang X. (2010). The pharmacological effects of morroniside and loganin isolated from Liuweidihuang Wan, on MC3T3-E1 cells. Molecules 15:7403–7414.
  • Liou SS, Liu IM, Hsu SF, Cheng JT. (2004). Corni fructus as the major herb of Die-Huang-Wan for lowering plasma glucose in Wistar rats. J Pharm Pharmacol 56:1443–1447.
  • Liou SS, Liu IM, Hsu JH, Wu YC, Hsu SF, Chen JT. (2002). Release of acetylcholine by Die-Huang-Wan to enhance insulin secretion for lowering plasma glucose in Wistar rats. Auton Neurosci 100:21–26.
  • Ma MK, Woo MH, McLeod HL. (2002). Genetic basis of drug metabolism. Am J Health Syst Pharm 59:2061–2069.
  • Oesterheld JR. (1998). A review of developmental aspects of cytochrome P450. J Child Adolesc Psychopharmacol 8:161–174.
  • Shen JJ, Lin CJ, Huang JL, Hsieh KH, Kuo ML. (2003). The effect of liu-wei-di-huang wan on cytokine gene expression from human peripheral blood lymphocytes. Am J Chin Med 31:247–257.
  • Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther 270:414–423.
  • Turpault S, Brian W, Van Horn R, Santoni A, Poitiers F, Donazzolo Y, Boulenc X. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928–935.
  • Wang P, Sun H, Lv H, Sun W, Yuan Y, Han Y, Wang D, Zhang A, Wang X. (2010). Thyroxine and reserpine-induced changes in metabolic profiles of rat urine and the therapeutic effect of Liu Wei Di Huang Wan detected by UPLC-HDMS. J Pharm Biomed Anal 53:631–645.
  • Wijnen PA, Op den Buijsch RA, Drent M, Kuijpers PM, Kuipers PM, Neef C, Bast A, Bekers O, Koek GH. (2007). Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms. Aliment Pharmacol Ther 26 (Suppl 2):211–219.
  • Wu CR, Lin LW, Wang WH, Hsieh MT. (2007). The ameliorating effects of LiuWei Dihuang Wang on cycloheximide-induced impairment of passive avoidance performance in rats. J Ethnopharmacol 113:79–84.
  • Wu YC, Hsu JH, Liu IM, Liou SS, Su HC, Cheng JT. (2002). Increase of insulin sensitivity in diabetic rats received die-huang-wan, a herbal mixture used in Chinese traditional medicine. Acta Pharmacol Sin 23:1181–1187.
  • Zheng Y. (2007). The therapeutic effects of rehmannia oral liquid for the syndrome of heat accumulation with Yin consumption in esophagus cancer patients undergoing radiotherapy–a report of 60 cases. J Tradit Chin Med 27:248–254.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.